IP Library Granted Patent US 10,010,706
Granted Patent B2
US 10,010,706 · App. 13/386,937 · Granted Jul 3, 2018

Hollow microneedle arrays

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,010,706
App. No.
13/386,937
Granted
Jul 3, 2018
Kind
B2
Abstract

The present disclosure relates to apparatus, assemblies, combinations, and methods for infusing fluids by hollow microneedles.

Claims (46)

1. An apparatus comprising:

a housing;

a drug cartridge comprising a tubular member, a piston movable within the tubular member, and a fluid, wherein the drug cartridge has an openable end sealed by a septum and the piston is in sliding and sealing relationship with the interior walls of the tubular member;

an applicator having a first major surface comprising a microneedle array, and a manifold carrier fixedly attached to the microneedle array;

a pathway communicable between the openable end and the microneedle array, the pathway passing through the manifold carrier;

the housing supporting the applicator and the drug cartridge;

a first stored energy device actuatable for applying force to the applicator to accelerate the applicator in a direction generally normal to the first major surface; and

a second stored energy device actuatable for automatically opening the openable end, such that the openable end and the pathway are in fluid communication, and wherein the second stored energy device includes a spring member that moves the piston relative to the housing so that the actuated second stored energy device forces the fluid through the openable end, the pathway, and the microneedle array; and

wherein the housing includes an actuator for actuating the first and second stored energy devices.

2. The apparatus of claim 1 , wherein the microneedle array includes an array of hollow microneedles.

3. The apparatus of claim 2 , wherein the first stored energy device drives the array of hollow microneedles at a velocity ranging from between about 2 and 20 m/sec.

4. The apparatus of claim 2 , wherein the first stored energy device is supported on the applicator so that upon full release of the first stored energy device the first stored energy device decouples therefrom and is allowed to freely recoil and vibrate.

5. The apparatus of claim 2 , wherein the housing includes a portion thereof that restrains movement of the applicator, thereby minimizing recoil and retraction of the array of hollow microneedles upon full release of the first stored energy device.

6. The apparatus of claim 2 , wherein the first stored energy device continuously maintains positive pressure on the applicator upon full release of the first stored energy device.

7. The apparatus of claim 2 , wherein the hollow microneedles of the array of hollow microneedles have a length of from about 500 μm to about 1000 μm.

8. The apparatus of claim 1 , wherein the first stored energy device comprises a spring that has leg portions that straddle the reservoir, and a portion that contacts the applicator and the spring has a generally U-shape, and when unstressed lies adjacent the reservoir and generally parallel to a longitudinal axis of the reservoir.

9. The apparatus of claim 1 , wherein the drug cartridge is removably replaceable in the housing.

10. The apparatus of claim 1 , wherein the applicator includes a piercing needle operable to penetrate the septum.

11. The apparatus of claim 1 , wherein the second stored energy device automatically displaces the drug cartridge along an axis generally parallel to the first major surface.

12. The apparatus of claim 1 , wherein the second stored energy device includes first and second spring members, wherein the first spring member moves the drug cartridge to open the openable end, and the second spring member moves the piston to force the fluid from the drug cartridge when the openable end is opened.

13. The apparatus of claim 1 , wherein the applicator is releasably held in a primed condition by a releasable latching mechanism cooperating with the first stored energy device.

14. The apparatus of claim 1 , wherein the second stored energy device drives the piston so as to infuse the fluid.

15. The apparatus of claim 1 , wherein the applicator comprises a releasable adhesive layer.

16. An apparatus comprising:

a housing;

a drug cartridge comprising a tubular member having a piston moveable within the tubular member, the drug cartridge storing a fluid and having an openable end sealed by a septum and the piston is in sliding and sealing relationship with the interior walls of the tubular member;

an applicator having a first major surface comprising a microneedle array, a manifold carrier fixedly attached to the microneedle array, and a pathway communicable between the openable end and the microneedle array, the pathway passing through the manifold carrier;

wherein the housing supports independently the applicator and the reservoir;

a first stored energy device actuatable for applying force to the applicator to accelerate the applicator in a direction generally normal to the first major surface;

a second stored energy device actuatable for automatically opening the openable end, such that the openable end and the pathway are in fluid communication, and wherein the actuated second stored energy device moves the piston relative to the housing and forces the fluid through the openable end, the pathway, and the microneedle array;

the housing including a single actuator operably connected to both the first and second stored energy devices and being actuatable for actuating the first and second stored energy devices.

17. An apparatus comprising:

a housing;

a drug cartridge comprising a tubular member, a piston movable within the tubular member, and a fluid, wherein the drug cartridge has an openable end sealed by a septum and the piston is in sliding and sealing relationship with the interior walls of the tubular member;

an applicator having a first major surface comprising a microneedle array, and a manifold carrier fixedly attached to the microneedle array;

a pathway communicable between the openable end and the microneedle array, the pathway passing through the manifold carrier;

the housing supporting the applicator and the drug cartridge;

a first stored energy device actuatable for applying force to the applicator to accelerate the applicator in a direction generally normal to the first major surface;

a second stored energy device actuatable for automatically opening the openable end, such that the openable end and the pathway are in fluid communication, and wherein the second stored energy device includes a spring member that moves the piston relative to the housing so that the actuated second stored energy device forces the fluid through the openable end, the pathway, and the microneedle array;

wherein the housing includes a single actuator for actuating the first and second stored energy devices; and

wherein the first and second stored energy devices comprise spring devices.

18. The apparatus of claim 17 , wherein the drug cartridge is removably replaceable in the housing.

19. The apparatus of claim 17 , wherein the applicator comprises a releasable adhesive layer.

20. The apparatus of claim 17 , wherein the applicator is releasably held in a primed condition by a releasable latching mechanism cooperating with the first stored energy device.

21. The apparatus of claim 17 , wherein the microneedle array includes an array of hollow microneedles.

22. The apparatus of claim 17 , wherein the housing including a single actuator operably connected to both the first and second stored energy devices and being actuatable for actuating the first and second stored energy devices.

Assignments (5)
SECURITY INTEREST Recorded Dec 14, 2022
From: KINDEVA DRUG DELIVERY L.P.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 062122/0618 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT R/F 053586/0715 Recorded Dec 12, 2022
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 062115/0707 →
SECURITY INTEREST Recorded Aug 24, 2020
From: KINDEVA DRUG DELIVERY L.P.
To: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
Reel/Frame 053586/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2020
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 052818/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2012
From: GONZALEZ, BERNARD A.; BURTON, SCOTT A.; HU, JIA; NG, CHIN-YEE; SIMMERS, RYAN PATRICK; GILBERT, THOMAS J.; BURKE, SEAN M.; HARKINS, ROBERT A.; SCHLEIF, LARRY A.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 027588/0752 →
Cited By (6)
US 12,398,094 US 12,440,133 US 12,441,745 US 12,446,810 US 12,582,617 US 12,611,530